Bayer’s Asia Pacific Regional Head Chris Lee On Bayer’s New Global R&D Center In Beijing And China’s Rising 21st Century Importance: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Bayer Schering Pharma Asia Pacific's Regional Head Chris Lee recently discussed with PharmAsia News' China Bureau Bayer's plans to create a new €100 million research and development center in Beijing and China's strengthening role in the company's 21st century blueprints for expansion. Bayer Schering's first global R&D center in Asia is slated to be operational by 2010, and will be the third in a triumvirate of research outposts that Bayer oversees worldwide (PharmAsia News, Feb. 19, 2009).